{
    "organizations": [],
    "uuid": "b023608de360f006733bc1ad228670871a0c09b1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-viking-therapeutics-announces-prop/brief-viking-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C3MX",
    "ord_in_thread": 0,
    "title": "BRIEF-Viking Therapeutics Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Viking Therapeutics Inc:\n* VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* VIKING THERAPEUTICS - INTENDS TO OFFER AND SELL, SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING\n* VIKING THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-02T05:12:00.000+02:00",
    "crawled": "2018-02-02T12:43:40.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "viking",
        "therapeutic",
        "inc",
        "viking",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "viking",
        "therapeutic",
        "intends",
        "offer",
        "sell",
        "share",
        "common",
        "stock",
        "underwritten",
        "public",
        "offering",
        "viking",
        "therapeutic",
        "inc",
        "intends",
        "use",
        "net",
        "proceeds",
        "offering",
        "continued",
        "development",
        "vk5211",
        "vk2809",
        "vk0214",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}